WILMINGTON, Del., May 09, 2024 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Prelude) (Nasdaq: PRLD), a clinical-stage precision oncology company, announced today that the Company will participate in the Citizens JMP Life Sciences Conference, taking place in New York City on May 13 and 14.
Prelude Therapeutics to Participate in Citizens JMP Life Sciences Conference
PRELUDE THERAPEUTICS INC
NASDAQ:PRLD (2/11/2025, 3:19:47 PM)
0.93
-0.16 (-14.68%)
PRLD Latest News and Analysis
a day ago - ChartmillStay updated with the stocks that are on the move in today's after-hours session.Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.
